Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
ramucirumab vascular endothelial growth factor receptor 2 biotech Successful target TTD , drugbank , DGIDB Unmarried[MeSHID:D012847]
Stomach[MeSHID:D013270]
Adenocarcinoma[MeSHID:D000230]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Malignant neoplasm of urinary bladder[MeSHID:D001749]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Liver carcinoma[MeSHID:D006528]		 0.7 approved,investigational antagonist
ramucirumab vascular endothelial growth factor receptor 2 biotech Successful target TTD , drugbank , DGIDB Unmarried[MeSHID:D012847]
Stomach[MeSHID:D013270]
Adenocarcinoma[MeSHID:D000230]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.7 approved,investigational antagonist,inhibitor
ramucirumab vascular endothelial growth factor receptor 2 biotech Successful target TTD , drugbank , DGIDB Unmarried[MeSHID:D012847]
Stomach[MeSHID:D013270]
Adenocarcinoma[MeSHID:D000230]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.7 approved,investigational antagonist,antibody
ramucirumab vascular endothelial growth factor receptor 2 biotech Successful target TTD , drugbank , DGIDB Unmarried[MeSHID:D012847]
Stomach[MeSHID:D013270]
Adenocarcinoma[MeSHID:D000230]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Malignant neoplasm of urinary bladder[MeSHID:D001749]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Liver carcinoma[MeSHID:D006528]		 0.7 approved,investigational antagonist,inhibitor
ramucirumab vascular endothelial growth factor receptor 2 biotech Successful target TTD , drugbank , DGIDB Unmarried[MeSHID:D012847]
Stomach[MeSHID:D013270]
Adenocarcinoma[MeSHID:D000230]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Malignant neoplasm of urinary bladder[MeSHID:D001749]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Liver carcinoma[MeSHID:D006528]		 0.7 approved,investigational antagonist,antibody
ramucirumab vascular endothelial growth factor receptor 2 biotech Successful target TTD , drugbank , DGIDB Unmarried[MeSHID:D012847]
Stomach[MeSHID:D013270]
Adenocarcinoma[MeSHID:D000230]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.7 approved,investigational antagonist
click here to return to the previous page